Prosecution Insights
Last updated: October 02, 2026
Application No. 17/904,923

BINDER FOR SECONDARY BATTERIES

Final Rejection §103
Filed
Aug 24, 2022
Priority
Feb 26, 2020 — JP 2020-030541 +1 more
Examiner
ARMSTRONG, KAREN JOYCE
Art Unit
1726
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sumitomo Seika Chemicals Co., Ltd.
OA Round
4 (Final)
69%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
24 granted / 35 resolved
+3.6% vs TC avg
Moderate +8% lift
Without
With
+7.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
45 currently pending
Career history
89
Total Applications
across all art units

Statute-Specific Performance

§101
1.7%
-38.3% vs TC avg
§103
64.9%
+24.9% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
11.0%
-29.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 35 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment filed on 07/20/2026 does not place the application in condition for allowance. In view of the amendment to claim 1 the rejection of claims 1-5 and 7-10 under 35 U.S.C. 103 is withdrawn. New analysis follows. Response to Arguments Applicant argues claim 1 is commensurate with unexpected binding force shown in the examples in Table 1, however these examples show a wide range of Hazen colors(36 to 312) with similar binding forces (examples 1-4) where only example 3(production example 4 polymer) is commensurate in scope with the newly amended claims including divinyl crosslinking agents, epoxy crosslinking agents, and metal crosslinking agents. Comparative examples 1 and 2 also do not have the claimed crosslinking agents. Furthermore, comparative example 1 changes one of the monomers as well as the polymerization catalyst, making the cause of the significant change in Hazen color and binding force difficult to ascertain and compare to the other examples. Comparative example 2 shows a completely different polymer with no crosslinking mentioned with a much higher Hazen Color but only a slightly lower binding force. Given the lack of crosslinking agent and the number of variables changing in each of the examples and comparative examples the arguments for unexpected results are not found persuasive. Applicant also argues that the Hazen color is not necessarily inherent in Mukai however, when the structure recited in the reference is substantially identical to that of the claims, claimed properties or functions are presumed to be inherent. The Courts have held that it is well settled that where there is a reason to believe that a functional characteristic would be inherent in the prior art, the burden of proof then shifts to the applicant to provide objective evidence to the contrary. See In re Schreiber, 128 F.3d at 1478, 44 USPQ2d at 1478, 44 USPQ2d at 1432 (Fed. Cir. 1997) (see MPEP § 2112.01, I.). Furthermore, applicant argues the Hazen color is dependent on a number of variables including crosslinking, monomer residues and other operations during the production process however it has not been shown what structure or operation within the polymer of modified Mukai, which meets all the limitations of claim 1, is not expected to be within the identified Hazen color range. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 and 7-10 are rejected under 35 U.S.C. 103 as being unpatentable over Mukai et. al. (US20150280237A1, in IDS) in view of Oshima et. al. (US20220336815A1). Regarding claims 1 and 10, Mukai discloses a mixture comprising a binder for a secondary battery (¶[0045]) comprising a polymer compound, wherein the polymer compound contains an acrylic repeating unit (¶[0131]-[0133] see methyl acrylate copolymer), wherein the polymer compound contains a) a repeating unit represented by formula (1): PNG media_image1.png 64 107 media_image1.png Greyscale wherein each R1 is independently a hydrogen atom and each R2 is an ONa group (see saponification step with sodium hydroxide producing the copolymer of First Formula with sodium in place of potassium (¶0050] and [0067]) and b} a repeating unit represented by formula 2:Formula 2 PNG media_image2.png 85 156 media_image2.png Greyscale wherein a molar ratio of the monomer forming the repeating unit represented by formula (1) to the monomer forming the repeating unit represented by formula (2) is 5/95 to 95/5(¶[0052]), and inherently a 3% by mass aqueous solution of the polymer compound has a Hazen color of 10 or more and 400 or less as it is the same material (vinyl alcohol/acrylic acid copolymer) produced by the same method as presented in the instant specification (¶[0072] of specification) with a Hazen color of 53 (¶[0083], Table 1 of specification). Regarding product and apparatus claims, when the structure recited in the reference is substantially identical to that of the claims, claimed properties or functions are presumed to be inherent. The Courts have held that it is well settled that where there is a reason to believe that a functional characteristic would be inherent in the prior art, the burden of proof then shifts to the applicant to provide objective evidence to the contrary. See In re Schreiber, 128 F.3d at 1478, 44 USPQ2d at 1478, 44 USPQ2d at 1432 (Fed. Cir. 1997) (see MPEP § 2112.01, I.). In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). MPEP §2144.05. Mukai does not disclose a first negative electrode active material consisting of silicon monoxide, and a second negative electrode material consisting of artificial graphite, wherein a mass ratio of the first negative electrode active material to the second negative electrode active material is 5/95 to 95/5, and wherein the polymer compound has a cross-linked structure formed by a crosslinking agent selected from the group consisting of divinyl crosslinking agents, epoxy crosslinking agents, metal crosslinking agents and a combination thereof. Oshima, related to secondary battery electrode materials, teaches a polyacrylic acid and polyvinyl alcohol based binder(¶[0238]) which may be crosslinked with an epoxy(¶[0103] or metal(¶[0073]) crosslinking agent and is useful to prepare a negative electrode containing artificial graphite and SiOx in a mass ratio of 5/95 to 95/5 where the SiOx may be silicon monoxide (SiO, ¶[0165]) and that this structure improves strength and flexibility of the electrode(¶[0103]). One of ordinary skill in the art would have recognized using the crosslinked binder of Mukai in the negative electrode of Oshima would improve strength and flexibility of the electrode. Therefore, it would have been obvious to have used the crosslinked binder of Mukai in the negative electrode of Oshima to improve strength and flexibility of the electrode. Regarding claims 7-9, Oshima further discloses a lithium-ion secondary battery comprising an electrode (¶[0033]) comprising the mixture of claim 1. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAREN J. ARMSTRONG whose telephone number is (703)756-1243. The examiner can normally be reached Monday-Friday 10 am-6 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jeffrey Barton can be reached at (571) 272-1307. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /K.J.A./Examiner, Art Unit 1726 /RYAN S CANNON/Primary Examiner, Art Unit 1726
Read full office action

Prosecution Timeline

Show 4 earlier events
Oct 07, 2025
Final Rejection mailed — §103
Jan 06, 2026
Request for Continued Examination
Jan 08, 2026
Response after Non-Final Action
Mar 12, 2026
Non-Final Rejection mailed — §103
Jun 18, 2026
Examiner Interview Summary
Jun 18, 2026
Applicant Interview (Telephonic)
Jul 10, 2026
Response Filed
Sep 11, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12749669
NEGATIVE ELECTRODE ACTIVE MATERIAL, AND ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS USING THE SAME
3y 11m to grant Granted Sep 29, 2026
Patent 12731831
RECHARGEABLE BATTERY
3y 9m to grant Granted Sep 08, 2026
Patent 12658470
SOLID ELECTROLYTE MATERIAL AND BATTERY USING SAME
3y 10m to grant Granted Jun 16, 2026
Patent 12658445
Binder for Secondary Battery, Negative Electrode for Secondary Battery Including the Same, and Lithium Secondary Battery Including the Same
3y 6m to grant Granted Jun 16, 2026
Patent 12646746
POSITIVE ELECTRODE LAYER, METHOD FOR MANUFACTURING POSITIVE ELECTRODE LAYER, AND ALL SOLID-STATE BATTERY
3y 6m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
69%
Grant Probability
76%
With Interview (+7.5%)
3y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 35 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month